Serum galectin 3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers
Yazarlar (9)
Unal Uluca
Dicle Üniversitesi, Türkiye
Velat Sen Dicle Üniversitesi, Türkiye
Aydin Ece
Dicle Üniversitesi, Türkiye
Ilhan Tan
Dicle Üniversitesi, Türkiye
Duran Karabel
Dicle Üniversitesi, Türkiye
Fesih Aktar Dicle Üniversitesi, Türkiye
Musemma Karabel
Dicle Üniversitesi, Türkiye
Hasan Balik
Dicle Üniversitesi, Türkiye
Prof. Dr. Ali GÜNEŞ Dicle Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Medical Science Monitor
Dergi ISSN 1234-1010
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 05-2015
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi 01-01-2015
Cilt / Sayı / Sayfa 21 / 1 / 1376–1380 DOI 10.12659/MSM.894035
Makale Linki http://doi.org/10.12659/MSM.894035
Özet
Background Chronic hepatitis B virus (HBV) infection is common worldwide. Follow-up of patients by the use of non-invasive techniques may be valuable in clinical practice. The aim of this study was to investigate serum galectin-3 (GAL-3) levels for monitoring disease status in children with chronic HBV infection. Material/Methods Thirty-two patients with chronic hepatitis B (CHB), 30 inactive HBV carrier patients, and 30 matched healthy controls were enrolled in the study. We performed basic laboratory tests: serum glucose, albumin, alanine aminotransferase (ALT), aspartate aminotransferase, gamma-glutamyl transferase (GGT), total bilirubin, prothrombin time, and activated partial thromboplastin time. In addition, serum GAL-3 levels were measured by ELISA technique. Results Significantly higher serum GAL-3 levels (16.5±3.6, 1.1±0.3, 0.7±0.5 ng/ml, respectively, p<0.001) and ALT levels (80.2±30.6, 26.8±12.6 …
Anahtar Kelimeler
Child | Chronic | Galectin 3 | Hepatitis B
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 33
Scopus 5
Web of Science 23
Serum galectin 3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers

Paylaş